Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04125524 | Terahertz Metamaterials for Tumour Marker Concentration Identification | suspended | — | 90 | Durham UniversityOTHER | 1 | Nov 1, 2023 | clinicaltrials |
| NCT03659669 | A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice(REVEAL) | suspended | — | 272 | AbbVieINDUSTRY | 1 | Oct 23, 2023 |
| clinicaltrials |
| NCT04485052 | Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia | suspended | Phase 1 / Phase 2 | 222 | Innovent Biologics (Suzhou) Co. Ltd.INDUSTRY | 1 | Oct 23, 2023 | clinicaltrials |
| NCT03859752 | TR1801-ADC in Patients With Tumors That Express c-Met | suspended | Phase 1 | 15 | Open Innovation Partners, Inc.INDUSTRY | 1 | Sep 22, 2023 | clinicaltrials |
| NCT04427306 | Neoadjuvant T-VEC in High Risk Early Melanoma | suspended | Phase 2 | 6 | University of California, DavisOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT01796795 | Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients | suspended | Phase 2 | 102 | G&E Herbal Biotechnology Co., LTDINDUSTRY | 0 | Sep 14, 2023 | clinicaltrials |
| NCT03229876 | Safety and Efficacy Evaluation of CD19-UCART | suspended | N/A | 20 | Bioray LaboratoriesINDUSTRY | 1 | Jul 24, 2023 | clinicaltrials |
| NCT03743428 | Biomarkers for Apatinib and Bevacizumab in Second-line Therapy for Colorectal Cancer(BABST-C)(BABST-C) | suspended | N/A | 40 | Shenzhen People's HospitalOTHER | 1 | Jun 29, 2023 | clinicaltrials |
| NCT03218475 | MRG FU With Radiotherapy for Palliation of H&N Cancer | suspended | N/A | 10 | Sunnybrook Health Sciences CentreOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT03055208 | Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma(Gamma-GBM) | suspended | N/A | 50 | Universitätsmedizin MannheimOTHER | 1 | May 11, 2023 | clinicaltrials |
| NCT03002103 | A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer | suspended | Phase 3 | 420 | SynCore Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 26, 2023 | clinicaltrials |
| NCT04650451 | Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors | suspended | Phase 1 | 220 | Bellicum PharmaceuticalsINDUSTRY | 1 | Apr 20, 2023 | clinicaltrials |
| NCT05158907 | Patient Reported Scale vs CTCAE Grading: A Prospective Comparator Study(PROSE) | suspended | N/A | 220 | Tata Medical CenterOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT02262221 | Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer(HETeCo) | suspended | N/A | 330 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 2 | Mar 13, 2023 | clinicaltrials |
| NCT05506800 | Guangzhou Women's Health Cohort Study (GWHCS) | suspended | — | 1,000,000 | Guangzhou Women and Children's Medical CenterOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT01933815 | Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma | suspended | Phase 1 / Phase 2 | 92 | Cortice Biosciences, Inc.INDUSTRY | 1 | Feb 22, 2023 | clinicaltrials |
| NCT04042116 | A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor | suspended | Phase 1 / Phase 2 | 227 | Clovis Oncology, Inc.INDUSTRY | 6 | Dec 20, 2022 | clinicaltrials |
| NCT03130946 | Comparison of Two Types of Biopsy in Suspicious Axillary Lymph Nodes | suspended | N/A | 135 | Peking University People's HospitalOTHER | 1 | Oct 18, 2022 | clinicaltrials |
| NCT04209023 | The Use of Navigated Transcranial Magnetic Stimulation (nTMS) in the Inhibition of Neurofunctional Regions of Interest | suspended | N/A | 10 | Neurological Associates of West Los AngelesOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT04746131 | Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL) | suspended | Phase 1 | 90 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc.OTHER | 1 | Sep 26, 2022 | clinicaltrials |
| NCT05089461 | A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant Tumor | suspended | Phase 2 | 120 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Sep 10, 2022 | clinicaltrials |
| NCT03970382 | A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors | suspended | Phase 1 | 21 | PACT Pharma, Inc.INDUSTRY | 1 | Aug 18, 2022 | clinicaltrials |
| NCT03704714 | Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma | suspended | Phase 1 / Phase 2 | 30 | Northwestern UniversityOTHER | 1 | Aug 15, 2022 | clinicaltrials |
| NCT04285697 | Infection Prevention Bundle in Brain Tumor Surgery | suspended | N/A | 300 | Istanbul University - CerrahpasaOTHER | 1 | Aug 4, 2022 | clinicaltrials |
| NCT03322813 | ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma | suspended | N/A | 15 | InSightecINDUSTRY | 1 | Aug 3, 2022 | clinicaltrials |
| NCT04116281 | Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery | suspended | N/A | 36 | Universidade Federal de Sao CarlosOTHER | 1 | Jul 12, 2022 | clinicaltrials |
| NCT01982175 | Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic Leukemia(CLL004) | suspended | Phase 2 | 120 | Shanghai Zhangjiang Biotechnology Limited CompanyINDUSTRY | 1 | Jun 21, 2022 | clinicaltrials |
| NCT03752541 | Efficacy and Safety Evaluation of BCMA-UCART | suspended | N/A | 20 | Bioray LaboratoriesINDUSTRY | 1 | May 20, 2022 | clinicaltrials |
| NCT00474331 | Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project | suspended | — | 2,000 | University of British ColumbiaOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT02121405 | Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM(PSSR) | suspended | Phase 3 | 350 | Zhejiang UniversityOTHER | 1 | May 11, 2022 | clinicaltrials |
| NCT02897050 | Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer | suspended | Phase 2 | 170 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Apr 20, 2022 | clinicaltrials |
| NCT04219475 | Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients(PROPHETIC) | suspended | — | 1,000 | OncoHost Ltd.INDUSTRY | 1 | Apr 19, 2022 | clinicaltrials |
| NCT02924714 | SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST | suspended | N/A | 31 | Oslo University HospitalOTHER | 1 | Feb 18, 2022 | clinicaltrials |
| NCT04506983 | GPC3-CAR-T Cells for the Hepatocellular Carcinoma | suspended | Phase 1 | 12 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT04697290 | CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients. | suspended | Early Phase 1 | 12 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT03081897 | Regional Anaesthesia and Substance P in Head and Neck Cancer(SPRANC) | suspended | N/A | 40 | Charite University, Berlin, GermanyOTHER | 1 | Feb 4, 2022 | clinicaltrials |
| NCT03945786 | Diagnostic Performance of Hybrid PET/MRI in the Staging of Endometrial Carcinoma | suspended | — | 120 | Xuanwu Hospital, BeijingOTHER | 1 | Dec 6, 2021 | clinicaltrials |
| NCT04985981 | The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study | suspended | — | 11,000 | Michel Adamina, MDOTHER | 1 | Dec 1, 2021 | clinicaltrials |
| NCT02910752 | CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation | suspended | Phase 1 / Phase 2 | 20 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Nov 26, 2021 | clinicaltrials |
| NCT03139747 | UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone | suspended | Phase 2 | 5 | Thomas Jefferson UniversityOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT04683120 | Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics | suspended | N/A | 100 | Laser LabCorpINDUSTRY | 1 | Jun 30, 2021 | clinicaltrials |
| NCT04250818 | Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile | suspended | — | 20 | Texas Tech University Health Sciences Center, El PasoOTHER | 1 | May 19, 2021 | clinicaltrials |
| NCT01562626 | Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors | suspended | Phase 1 / Phase 2 | 75 | Anaeropharma Science, Inc.INDUSTRY | 1 | May 12, 2021 | clinicaltrials |
| NCT04835025 | Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer | suspended | — | 200 | Tongji HospitalOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT03722186 | Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies | suspended | Phase 1 | 128 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Mar 22, 2021 | clinicaltrials |
| NCT04084158 | A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. | suspended | Phase 2 | 100 | Zhejiang Cancer HospitalOTHER | 1 | Feb 23, 2021 | clinicaltrials |
| NCT04001010 | Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia(SERENITY) | suspended | Phase 3 | 334 | Tetra Bio-PharmaINDUSTRY | 1 | Feb 5, 2021 | clinicaltrials |
| NCT00738777 | Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer | suspended | Phase 2 | 250 | The Netherlands Cancer InstituteOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT03839277 | Adenoma Detection Rate Using Endocuff Vision in China(SinoEVADR) | suspended | N/A | 1,200 | Changhai HospitalOTHER | 1 | Sep 28, 2020 | clinicaltrials |
| NCT04474652 | Guide for Prioritisation of Patients for Referral to Breast Clinics | suspended | — | 4,000 | The Leeds Teaching Hospitals NHS TrustOTHER | 1 | Jul 17, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Nov 1, 2023source: clinicaltrials